DALVANCE CONNECTS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 20 Oct 2023)
What this means for you
Registered since 23 May 2017. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 86599427
- Registration number
- 5209877
- Mark type
- Stylized text
- Filed
- 16 Apr 2015
- Published for opposition
- 08 Sept 2015
- Registered
- 23 May 2017
- Attorney of record
- Janie L. Thompson
Goods and services
- Class 036 — Insurance and financial services: Providing information about patient reimbursement and insurance coverage for pharmaceuticals
Owner
- ALLERGAN PHARMACEUTICALS INTERNATIONAL LIMITED, DUBLIN 17, IE
- Durata Therapeutics Holding C.V., George Town, Grand Cayman, NL
- Durata Therapeutics Holding C.V., George Town, Grand Cayman, NL
- Durata Therapeutics Holding C.V., Grand Cayman, NL
Prior registrations
Prosecution history
- 20 Oct 2023 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 20 Oct 2023 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 20 Oct 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 24 Apr 2023 — TEAS SECTION 8 & 15 RECEIVED
- 23 May 2022 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 19 Dec 2018 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 23 May 2017 — REGISTERED-PRINCIPAL REGISTER
- 18 Apr 2017 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 17 Apr 2017 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 01 Apr 2017 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Mar 2017 — USE AMENDMENT FILED
- 30 Mar 2017 — TEAS STATEMENT OF USE RECEIVED
- 22 Mar 2017 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Mar 2017 — SOU EXTENSION 2 GRANTED
- 03 Nov 2016 — SOU EXTENSION 2 FILED